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Abstract
Bluetongue virus (BTV) is the ‘type’ species of the genus Orbivirus within the family Reoviridae. The BTV genome is composed
of ten linear segments of double-stranded RNA (dsRNA), each of which codes for one of ten distinct viral proteins. Previous
phylogenetic comparisons have evaluated variations in genome segment 3 (Seg-3) nucleotide sequence as way to identify
the geographical origin (different topotypes) of BTV isolates. The full-length nucleotide sequence of genome Seg-3 was
determined for thirty BTV isolates recovered in the eastern Mediterranean region, the Balkans and other geographic areas
(Spain, India, Malaysia and Africa). These data were compared, based on molecular variability, positive-selection-analysis and
maximum-likelihood phylogenetic reconstructions (using appropriate substitution models) to 24 previously published
sequences, revealing their evolutionary relationships. These analyses indicate that negative selection is a major force in the
evolution of BTV, restricting nucleotide variability, reducing the evolutionary rate of Seg-3 and potentially of other regions
of the BTV genome. Phylogenetic analysis of the BTV-4 strains isolated over a relatively long time interval (1979–2000), in a
single geographic area (Greece), showed a low level of nucleotide diversity, indicating that the virus can circulate almost
unchanged for many years. These analyses also show that the recent incursions into south-eastern Europe were caused by
BTV strains belonging to two different major-lineages: representing an ‘eastern’ (BTV-9, -16 and -1) and a ‘western’ (BTV-4)
group/topotype. Epidemiological and phylogenetic analyses indicate that these viruses originated from a geographic area
to the east and southeast of Greece (including Cyprus and the Middle East), which appears to represent an important
ecological niche for the virus that is likely to represent a continuing source of future BTV incursions into Europe.
Citation: Nomikou K, Dovas CI, Maan S, Anthony SJ, Samuel AR, et al. (2009) Evolution and Phylogenetic Analysis of Full-Length VP3 Genes of Eastern
Mediterranean Bluetongue Virus Isolates. PLoS ONE 4(7): e6437. doi:10.1371/journal.pone.0006437
Editor: Justin Brown, University of Georgia, United States of America
Received March 19, 2009; Accepted May 2, 2009; Published July 30, 2009
Copyright:  2009 Nomikou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by European Union -Grant ReoID number QLK2-2000-00143 ‘Phylogenetic sequence analysis and improved diagnostic assay
systems for viruses of the family Reoviridae’ Staff at IAH were also funded by BBSRC(Biotechnology and Biological Sciences Research Council) and Defra
(Department for Enviromental Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: peter.mertens@bbsrc.ac.uk
Introduction
Bluetongue virus (BTV) is the ‘type’ species of the genus Orbivirus
within the family Reoviridae [1]. The BTV genome is composed of
ten linear segments of double-stranded RNA (dsRNA), each of
which codes for one of ten distinct viral proteins [2,3]. The
genome segments are packaged within an icosahedral capsid,
,80 nm in diameter, composed of three concentric protein layers.
The innermost ‘subcore’ shell is constructed from 12 decamers of
VP3, surrounding the virus genome and viral transcriptase
complexes composed of three minor structural proteins (VP1[Pol],
VP4[CaP] and VP6[Hel]) that are attached to the inner surface of
the sub-core layer [4]. The self-assembly of VP3 to form the BTV
subcore, is thought to play a vital role in the early stages of virion
assembly and replication [5,6]. Once assembled, the subcore-shell
provides a ‘scaffold’ for addition of 780 copies of VP7 (organized
as 260 trimers) to form the core-surface layer, followed by addition
of 60 trimers of VP2 and 120 trimers of VP5 to form the outer-
capsid [3,7,8]. In BTV-infected cells there are also three distinct
non-structural proteins (NS1, NS2 and NS3/NS3A) [2,3].
VP3 interacts with both the minor proteins of the transcriptase
complexes and the dsRNA of the viral genome, and consequently
also helps to determine the internal structure of the particle [9].
This internal organization is considered to be important for the
simultaneous synthesis of mRNA copies from the ten genome
segments by the virus-core during replication within the infected
cell [10]. The amino acid sequence of VP3, which determines the
protein structure, therefore also determines both the overall size of
the outer-layers and the internal organization of the BTV virus
particle.
VP3 is encoded by genome segment 3 (Seg-3) and is composed
of 901 amino acids, which form an elongated triangular protein
that can be divided into apical, carapace, and dimerization
domains [4,11]. The amino acid sequence of VP3 (and the
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6437nucleotide sequence of Seg-3) is highly conserved within the
species BTV and shows significant levels of conservation even
between different Orbivirus species [1,12,13]. Indeed Seg-3 is one of
the most conserved regions of the BTV genome [13], reflecting
major structure/function constraints on VP3, as well as its internal
position within the virus particle which protects it from exposure
to neutralizing antibodies and ‘antibody selective pressure’.
Despite these constraints, both Seg-3 and VP3 do show significant
variations that reflect the geographic origins of the virus, dividing
individual isolates into eastern and western groups/topotypes, and
a number of further sub-groups [13,14].
Bluetongue (BT) is an arthropod-transmitted disease of wild and
domestic ruminants, which can spread rapidly under suitable
circumstances. It has therefore been included in the ‘list of
notifiable diseases’ (former list A) by the Office International des
Epizooties (OIE) [15], and represents a major barrier to
international trade in ruminants and their products, causing
worldwide losses that were estimated in 1996 at US$3 billion per
year [16].
Twenty four distinct serotypes of BTV have been detected
around the world, between latitudes 40uS and 53uN (in the
Americas, Africa, Asia and Australia and Europe), although not all
of these serotypes occur in each region (www.reoviridae.org/
dsRNA_virus_proteins/btv-serotype-distribution.htm). In 2008 a
virus from goats in Switzerland (Toggenburg orbivirus) was
provisionally identified as a further 25
th distinct serotype (BTV-
25) [17]. Prior to 1998, outbreaks of BT had occasionally been
detected in Europe, although in most cases these were relatively
short lived (,4–5 years) and involved a single BTV strain/
serotype on each occasion (reviewed by Mellor [18]). However in
1998, a major series of BT incursions began in Europe, involving
BTV-1, -2, -4, -6, -8 -9, -11 and -16 (see www.reoviridae.org/
dsRNA_virus_proteins/outbreaks.htm; [13,19,20,21]. These out-
breaks started in the eastern Mediterranean region (in Greece)
before spreading westwards across the Balkans and southern
Europe (www.reoviridae.org/dsRNA_virus_proteins/ReoID/
BTV-mol-epidem.htm; [18,22,]. Although BTV incursions from
the east and from North Africa were initially restricted to
Mediterranean Europe, during August 2006 an outbreak caused
by BTV-8 was detected in the Netherlands. This was the first time
that BT had ever been recorded in northern Europe and
represented the start of the largest single outbreak of BT on
record, subsequently spreading across the whole of northern and
central Europe 2008 [13,18,23].
The first recorded incursion of BT in Greece during 1979 was
caused by BTV-4, on the island of Lesbos in the eastern Aegean
Sea [24]. Although measures to control the disease were successful
and Greece was subsequently declared BTV free in 1991, a new
incursion began in the eastern Aegean region during 1998,
followed by a number of major epizootics between 1998 and 2000
that involved a western topotype of BTV-4 and to a lesser extent,
eastern topotypes of BTV-9 and BTV-16. In 2001 a further
incursion was caused by an eastern topotype of BTV-1 [25], and
in December 2008 both BTV-8 (western topotype) and BTV-16
(eastern topotype) were detected in Greece (see: www.reoviridae.
org/dsRNA_virus_proteins/ReoID/virus-nos-by-country.
htm#Greece).
Reassortment, genetic drift and founder effects during sequen-
tial passage of BTV between its insect and ruminant hosts,
contribute to the diversification and independent evolution of each
BTV segment [26]. Phylogenetic analyses based on the complete
or partial nucleotide sequences of different segments have been
carried out to determine the genetic relationships and/or
geographic origins of different BTV isolates. These studies have
involved genes encoding conserved proteins e.g. Seg-9, encoding
VP6 [27], or the more variable Seg-10 encoding NS3/NS3A
[28,29,30,31] and the most variable outer-capsid proteins VP2
and VP5, encoded by Seg-2 and Seg-6 respectively [13,32–38].
Comparisons of the full genome of the northern European
strain of BTV-8 to other European isolates, have confirmed Seg-2
and -6 as the most variable components of the BTV genome [13],
showing variations that correlate with both virus serotype and the
geographic origins (topotype) of the virus isolate. Genome
segments 7 and 10, encoding VP7 and NS3, show intermediate
levels of variation, dividing isolates into a number of clades that
show only partial correlation with virus topotype [13]. The
remaining variations in Seg-7 and Seg-10 have as yet unconfirmed
significance, although it has been suggested that they may relate to
transmission of the virus by different insect vector species/
populations [13,39,40,]. The remaining six genome segments
(Seg-1, -3, -4, -5, -8 and 9; encoding VP1, VP3, VP4, NS1, NS2
and VP6, respectively) are all highly conserved, showing variations
that correlate primarily with virus origin, dividing isolates into
eastern and western topotypes and providing evidence of
geographic subgroups, but no significant correlation with virus
serotype (supplementary data, [13]).
Previous phylogenetic comparisons have evaluated variations in
Seg-3 nucleotide sequence as way to identify the geographical
origin (different topotypes) of BTV isolates [13,14,41]. These
analyses have previously identified two major topotypes (eastern
and western), represented by the Australasian, or American and
African viruses respectively. However, an Australian isolate of
BTV-15, and the Swiss isolate of BTV-25 appear likely to
represent two further divergent groups or distinct topotypes. These
genetic relationships have been inferred mostly using a partial
(540 bp) fragment [14,42], or in a few cases using a small number
(one or two) of full-length Seg-3 sequences [41].
The study presented here analysed the full-length sequence of
Seg-3 from twenty BTV isolates recovered during the 1979 and
1998–2001 epizootics of BT in eastern Mediterranean countries
and the Balkans. Ten other reference strains, or field isolates of
BTV from other locations, were included in these analyses. The
sequence data generated were also compared to twenty four Seg-3
sequences from other BTV isolates that have previously been
published, to elucidate the geographic origins of the European
viruses and provide data concerning the relationships and
evolution of Seg-3./p>
Materials and Methods
Virus isolates
Genome segment 3 was sequenced from thirty BTV isolates,
including twenty isolates from Greece, Cyprus, Bulgaria, Turkey
and Israel, six isolates from Spain, Morocco, Nigeria, Sudan,
Malaysia and India and four reference strains (Table 1, Figure 1).
The Greek BTV strains were isolated from ruminants during
epizootics in 1979 and 1998–2001, using BHK-21 cells (ECACC
85011433) or embryonated chicken eggs, followed by passage in
BHK-21 cells [43,44]. Initial EDTA blood samples were taken from
sick or sentinel animals, while spleen samples were taken at post-
mortem. Isolates were serotyped by serum neutralization tests
(SNTs) as described in the OIE Manual of Diagnostic Tests and
Vaccines for Terrestrial Animals [45], using type specific antisera
provided by the OIE Reference Laboratory at the Onderstepoort
Veterinary Institute, Onderstepoort, South Africa. Each of these
virus isolates is included in the reference collection at IAH Pirbright
(see www.reoviridae.org/dsRNA_virus_proteins/ReoID/BTV-iso-
lates.htm)andisidentifiedherebytheirreferencecollectionnumber.
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dsRNA was extracted from pellets of BTV infected BHK-21
cells using TrizolH LS reagent (Invitrogen) as described by Attoui
et al. [46] and used for amplification of full-length cDNAs using a
self-priming ‘anchor-primer’, as described by Maan et al. [47].
Briefly a 35 base single-stranded self-priming oligonucleotide
‘‘anchor-primer’’ (59 p-GAC CTC TGA GGA TTC TAA AC /
iSp9/ T CCA GTT TAG AAT CC-OH 39) was ligated to the 39
(uncapped) termini of unfractionated BTV genomic dsRNA [47].
The ‘ligated’ dsRNA was denaturated, and then used for the
synthesis of cDNA copies, primed by the base paired ‘hairpin’
structure of the anchor-primer. The ligation reactions were carried
out at 37uC for 40 min, in a total volume of 40 ml, containing:
1.0 mg of dsRNA, 0.5 ml (0.25 mg) of anchor-primer (Integrated
DNA Technology, USA), 2 ml of T4 DNA and RNA ligase buffers
(Promega), 1 ml of RNasin (2 U/ml, Promega), 20 ml of Polyeth-
ylene Glycol (PEG, Sigma) and 0.5 ml each of T4 RNA and DNA
ligase enzymes (at 10 U/ml and 3 U/ml respectively, Promega).
Fractionation and purification of RNA segments
After ligation to the ‘‘anchor-primer’’, the dsRNA genome
segments of BTV were separated by electrophoresis in 0.9%
agarose gels using Tris-Acetate/EDTA electrophoresis buffer (16
TAE), pH 8.0. The segments were excised from the agarose gels
and extracted using the QIAquickH Gel extraction kit (Qiagen)
according to the manufacturer’s instructions. Seg-2 and -3 were
Table 1. BTV field isolates sequenced in this study. Further details of the isolates can be obtained from the dsRNA virus reference
collection (www.reoviridae.org/dsRNA_virus_proteins/ReoID/BTV-isolates.htm).
Abbreviations
1
IAH
2 dsRNA virus reference
collection number
Passage History
(E
3/BHK-21
4)
Seg-3 Sequence
Accession Number Area of isolation Tissue Host species
4/GR1/79 GRE 1979/01 E2/BHK6 DQ 186823 Lesvos, Greece Spleen Sheep
4/GR180/99 GRE 1999/01 E2/BHK4 DQ 186800 Rhodes, Greece Blood Sheep
4/GR631/99 GRE 1999/04 E2/BHK7 DQ 186801 Magnesia, Greece Blood Sheep
4/GR228/99 GRE 1999/07 E2/BHK4 DQ 186802 Evros, Greece Blood Goat
4/GR378/99 GRE 1999/09 E2/BHK7 DQ 186803 Chios, Greece Blood Bovine
4/GR395/99 GRE 1999/10 E2/BHK5 DQ 186804 Lesvos, Greece Spleen Sheep
4/GR279/99 GRE 1999/15 E2/BHK6 DQ 186809 Rodopi, Greece Spleen Sheep
4/GR1217/00 GRE 2000/07 E2/BHK3 DQ 186806 Arta, Greece Blood Sheep
9/GR408/99 GRE 1999/12 E2/BHK4 DQ 186805 Chalkidiki, Greece Blood Sheep
9/GR199/98 GRE 1998/01 E2/BHK9 DQ 186808 Rhodes, Greece Blood Sheep
16/GR308/99 GRE 1999/13 E2/BHK9 DQ 186821 Rhodes, Greece Blood Sheep
1/GR1245/01 GRE 2001/05 E1/BHK9 DQ 186822 Ioannina, Greece Spleen Sheep
1/GR15/01 GRE 2001/06 BHK8 DQ 186820 Grevena, Greece Spleen Sheep
1/GR1472/01 GRE 2001/07 BHK3 DQ 189807 Lesvos, Greece Blood Sheep
16/CYP/04 CYP 2004/01 Vero1/BHK4 DQ186798 Ammochostos, Cyprus Blood Sheep
4/CYP/04 CYP 2004/03 CPAE1/BHK6 DQ186799 Ammochostos, Cyprus Spleen Sheep
16/ISR/01 ISR 2001/18 E1/BHK4 DQ186814 Yokneam, Israel Blood Sheep
4/ISR/01 ISR 2001/01 E1/BHK2 DQ186813 Bat Slomo, Israel Blood Sheep
16/TUR/00 TUR 2000/01 E3/BHK9 DQ186827 Izmir, Turkey - -
9/BUL/99 BUL 1999/01 E1/BHK5 DQ186797 Bulgaria - -
4/SPA/03 SPA 2003/01 E1/BHK4 DQ186824 Menorca, Spain Blood Sheep
4/MOR/04 MOR2004/02 E1/BHK4 DQ186817 El Kebir, North Morocco Blood Sheep
1/NIG/82 NIG 1982/01 E1/BHK3 DQ 186818 Nigeria - -
4/SUD/83 SUD 1983/01 E1/BHK2 DQ186825 Sudan - -
1/MAY/87 MAY1987/01 E1/BHK2 DQ 186816 Kuala Lumpur, Malaysia - -
1/INDIA/01 IND 2001/01 BHK6 DQ 186811 Chennai, India - Culicoides spp.
1/REF
5 RSArrrr/01 E2/BHK9 DQ186792 OVI - South Africa - -
4/REF
5 RSArrrr/04 BHK9 DQ186794 OVI - South Africa
(Cyprus 1969)
--
16/REF
5 RSArrrr/16 E2/BHK7 DQ186796 OVI - South Africa (Pakistan) - -
9/REF
5 RSArrrr/09 E3/BHK8 DQ186795 OVI - South Africa - -
1Serotype/origin (GR: Greece, NIG: Nigeria, MAY: Malaysia, INDIA: India, CYP: Cyprus, ISR: Israel, TUR: Turkey, BUL: Bulgaria, SUD: Sudan, SPA: Spain, MOR: Morocco, REF:
Reference strain)/year of isolation.
2Institute for Animal Health, Pirbright Laboratory, UK.
3Number of passages in embryonated chicken eggs.
4Number of passages in BHK-21 cell culture.
5Reference strains of BTV were provided by the Onderstepoort Veterinary Research Institute, including strains of BTV-1 (1958) and BTV-9 (1942) from a South-African
origin. However, the strains of BTV-4 and -16 were isolated in Cyprus (1969) and Pakistan (1960) respectively [83,84].
doi:10.1371/journal.pone.0006437.t001
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The ligated RNA was eluted in 30 ml of RNase-DNase free water.
cDNA first strand synthesis
The recovered, ligated-RNA (2.5 ml) was denatured and reverse
transcription (RT) was performed at 50uC for 50 min using the
Superscript
TM III First-Strand Synthesis System for RT-PCR
(Invitrogen), followed by 85uC for 5 min. The 20 ml reaction
volume contained: 4 ml of 25 mM MgCL2,1ml of 10 mM each
dNTP mix, 1 ml (200 U/ml) of Superscript
TM III, 1 ml (40 U/ml) of
RNaseOUT
TM,2ml of 0.1 M DTT, 2 ml of 10X RT buffer, 3 mlo f
RNase-DNase free water and 6 ml of denaturated RNA. After RT,
1 ml of RNase H (2 U/ml, Invitrogen) was added to the reaction,
which was incubated at 37uC for 25 min, followed by denaturation
at 95uC for 5 min. The primary cDNA strands were re-annealed by
lowering the temperature from 95uCt o8 0 uC, at a rate of 1uC per
min,thento50uCata rateof1uCper3 minandincubationat50uC
for 10 min. The completed cDNA copies were diluted by addition
of 50 ml of RNase-DNase free water and stored at 220uC.
PCR amplification of cDNAs
Amplification of cDNAs was performed using the primer 5-15-1
(59-GAGGGATCCAGTTTAGAATCCTCAGAGGTC-39) [47]
and the Triplemaster
TM PCR system (Eppendorf) in a 20 ml
reaction mixture containing 2 ml of the annealed primary cDNA
product, 2 ml of 10X HiFidelity Buffer, 0.4 ml of dNTPs mix
(10 mM each), 0.25 ml( 5U / ml) of Triplemaster
TM enzyme, 1 ml
of 100 mM 5-15-1 primer, and 15.4 ml of RNase-DNase free
water. After denaturation at 94uC for 2 min, amplification was
carried out for 35 cycles of 95uC for 20 sec and 68uC for 4.5 min
followed by a final extension step at 72uC for 10 min.
Sequencing and sequence analysis
The amplified RT-PCR products were analysed by 0.9%
agarose gel electrophoresis for 6 hours, in TAE buffer. This was
carried out at +4uC, to improve the separation of Seg-2 and Seg-3
and recovered from the gel using the GFX
TMPCR DNA and Gel
Band Purification Kit (Amersham Biosciences) according to the
manufacturer’s instructions. The purified DNA was sequenced in
both directions using BTV-specific terminal ‘phased’ primers
PHX-F (59-AGAATCCTCAGAGGTCGTTAAA-39) and PHX-
R( 5 9-AGAATCCTCAGAGGTCGTAAGT-39) [37,47], as well
as walking-sequencing primers (data not shown). Sequencing was
carried out using the ‘‘Quick Start Mix’’ kit (CEQ DTCS
Beckman Coulter) and reactions were run on a Beckman CEQ
TM
8000 Automated Capillary Sequencer according to the manufac-
turer’s instructions. The resulting sequence data were analysed
using BioEdit Sequence Alignment Editor (version 7.0.5.2) [48].
Figure 1. Map of geographical location of the isolates analysed in this study and the sources of BTV incursions in Europe.
doi:10.1371/journal.pone.0006437.g001
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GenBank and the accession numbers obtained are provided in
Table 1.
The Seg-3 sequences generated (Table 1), were aligned with
other published sequences (Table 2) using ClustalX version 1.8
[49]. They were further analyzed using DnaSP version 4.10.9 [50]
for calculating nucleotide diversity ‘Pi’ (the average number of
nucleotide differences per site between two sequences). ‘Dxy’
represents the mean distance between two sequence groups (the
average number of nucleotide substitutions per site between the
two populations) [51].
Phylogenetic and positive selection analysis
The best nucleotide substitution model selected by Modeltest
3.8 for the Seg-3 coding region sequence data set, was the General
Time Reversible with gamma distributed rates across sites and a
fraction of sites assumed to be invariable (GTR + I + C) [52].
Recombination can adversely affect the power and accuracy of
phylogenetic reconstruction [53] and may result in higher rates of
false positives in maximum likelihood tests for positive selection
[54]. Therefore, the data was initially checked for evidence of
recombination, using the Genetic Algorithm for Recombination
Detection (GARD), www.datamonkey.org/GARD, [55]. The
aligned sequence data set for the whole coding region of Seg-3
from 54 isolates (Table 1 and 2) was used for phylogenetic
analyses. The best fitting nucleotide substitution model was
selected by Modeltest 3.8 program [52] using the Akaike
Information Criterion (AIC). Maximum likelihood (ML) phyloge-
netic trees were constructed with PhyML using a hill-climbing
algorithm that adjusts tree topology and branch lengths simulta-
neously [56]. The reliability of the phylogenetic hypothesis was
assessed using non-parametric bootstrap (NPB) analysis. The
resulting tree was midpoint rooted using MEGA version 3.1 [57].
Phylogenetic analyses of the 59 (nucleotides 36 to 908), middle
(nucleotides 909 to 1778) and 39 (nucleotides 1779 to 2648) regions
of the Seg-3 were conducted in a similar manner. These regions
have similar lengths and encode amino acid regions 7–297, 298–
587 and 588–877 respectively that correspond to specific domains
of VP3 (Figure 2).
Positive selection analysis at single amino acid sites was
performed separately for the eastern (Australasian) and western
(N
th American/S
th African) lineages. For each of these aligned data
sets we estimated the rates of non-synonymous and synonymous
changes at each site, using likelihood-based methods as implement-
ed in the on-line Datamonkey server (http://www.datamonkey.org;
[58,59] (Figure 3). These analyses used: i) a conservative single-
likelihood ancestor-counting (SLAC) method, which is related to
that of Suzuki–Gojobori [60] and ii) a fixed-effects likelihood (FEL)
Table 2. BTV isolates and published Seg-3 sequences used for sequence analysis. Further details of the isolates can be obtained
from the dsRNA virus reference collection (www.reoviridae.org/dsRNA_virus_proteins/ReoID/BTV-isolates.htm).
Abbreviations
1 IAH
2 dsRNA virus reference collection number Seg-3 Sequence Accession Number Area of isolation
16/ZIM/03 ZIM 2003/10 DQ186828 Zimbabwe
16/NIG/82 NIG 1982/10 DQ186819 Nigeria
2/TUN/00 TUN 2000/01 DQ186826 Tunisia
2/ITL/02 ITL 2002/07 DQ186815 Sicily - Italy
23/INDIA/98 IND 1998/01 DQ186810 Bangalore, southern India
16/INDO/91 ISA 1991/01 DQ186812 Indonesia
9/AUS/85 AUS 1985/01 DQ186790 Australia
16/AUS/86 AUS 1986/02 DQ186791 Australia
2/CORS/00 - AY124371 Corsica-France
2/OnaAUSA/95 - S78452 USA
17/USA/97a - AF017280 USA
11/USA/94 - L19968 USA
17/USA/85 - M32722 USA
13/USA/94 - L19969 USA
17/USA/97 - AF017281 USA
10/USA/85 - NC006014 USA
1/AUSAsia - AF529048 AUSTRALASIA
3/INDO/90 - AF529045 West Java-Indonesia
2/TAIW/03 - AY493688 Kinmen island -Taiwan
6/INDO/90 - AF529047 West Java-Indonesia
21/INDO/90 - AF529046 West Java-Indonesia
1/AUS/79 - AY322428 Australia
1/INDO/90 - AF529044 West Java-Indonesia
2/REF RSArrrr/02 DQ186793 OVI - South Africa
1Serotype/origin (ZIM: Zimbabwe, NIG: Nigeria, TUN: Tunisia, ITL: Italy, INDIA: India, AUS: Australia, CORS: Corsica, USA: USA, AUSAsia: Australasia, INDO: Indonesia, TAIW:
Taiwan, REF: Reference strain)/year of isolation.
2Institute for Animal Health, Pirbright Laboratory, UK.
doi:10.1371/journal.pone.0006437.t002
VP3 Genes of BTV Isolates
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synonymous substitution rates at each site (this method is more
appropriate for data sets with a moderate number of sequences)
[58]. For these analyses an optimal model of nucleic acid selection
was selected by the methods available on the Datamonkey website
using neighbour joining phylogenetic trees. The SLAC method was
also used to calculate the global ratio of non-synonymous
substitutions per non-synonymous site (dN) to synonymous substi-
tutions per synonymous site (dS) (expressed as dN/dS) and estimate
the 95% confidence interval for each dataset.
Results
Sequence and phylogenetic analysis of Seg-3
The BTV Seg-3 sequences analysed were all 2772 bp in length,
containing a single open reading frame of 2706 bp, from
nucleotide 18 to 2723 encoding VP3 protein of 901 amino acids
(aa). In all sequences, an initiation codon (ATG) was located at
positions nt 18–20, with a termination codon (TAG) at positions nt
2721–2723. In each case the coding region was flanked by 17 bp
59 and 49 bp 39 non-coding regions (NCRs) and the nucleotide
sequence alignment showed no evidence of insertions or deletions.
The majority of the nucleotide changes detected were silent,
occurring in the third base position of each codon. The Seg-3
sequence was highly conserved, even between isolates belonging to
different serotypes. No evidence for recombination was found
using the GARD algorithm.
Comparisons of VP3 amino acid sequences from the fifty four
BTV isolates revealed an extremely high overall level of
conservation, with polymorphic positions representing only
7.77% of the amino acid sites. All of the VP3 sequences contained
a low content of charged amino acids (less than 24.87%) and a
high content of hydrophobic and non-polar residues. The
hydrophobic residues constituted 46.18% of the protein. Two
amino acids (residues 500 (M) and 502 (R)), which were previously
identified as critical for assembly of virus cores [12], were also
conserved in all of the sequences described here. Residues 307–
328 of VP3 (T2)A, which lie immediately within the VP3 (T2)
layer [9] and form strong interactions with the dimeric ‘capping’
enzyme VP4(CaP) [61], were also conserved in all isolates.
When the two main geographic lineages of VP3 were
considered separately, the percentage of polymorphic positions
was even lower (4.1% in western-topotype and 3.77% in the
eastern-topotype). Twenty one parsimony-informative sites were
identified (positions containing at least two types of amino acids
and at least two of them occurring with a minimum frequency of
two). Most of these substitutions were conservative with Ile«Val
being the most frequent. Positions 213, 244, 461, 595, 786, and
811 were different between, but conserved within the eastern and
western topotypes (Figure 2).
ML phylogenetic analysis of Seg-3 nucleotide sequences also
demonstrated the existence of two divergent lineages/topotypes,
which correspond to the ‘eastern’ (Australasian) and ‘western’ (N
th
American/S
th African) groups of BTV isolates (Figure 3).
Nucleotide diversity within each lineage was similar (eastern
Pi=0.0779, SD=0.003; western Pi=0.064, SD=0.0065). The
overall percentage nucleotide similarity was 78.9%–99.8% within
the eastern group and 89.3%–99.9% within the western group.
The mean distance between these lineages, expressed as the
average number of nucleotide substitutions per site between the
two populations, was Dxy=0.1919.
Seg-3 from each of the Greek isolates (GRE1979/01,
GRE1999/01, GRE1999/04, GRE1999/07, GRE1999/09,
GRE1999/10, GRE1999/15, GRE2000/07) and the Cypriot
isolate (CYP2004/03) of BTV-4, belongs to the western group.
These sequences are closely related to the reference strain
RSArrrr/04, which was also isolated in Cyprus (1969) (Figure 3),
showing high overall nucleotide similarity of 99.5%–99.9%
(Pi=0.0027, SD=0.0005) with thirty two nt changes, but only
one aa change between the more recent isolates and GRE1979/01
or RSArrrr/04 (1969). These BTV-4 isolates represent an eastern
Mediterranean cluster that is closely related to the reference strain
of BTV-1 (RSArrrr/01) and the Israeli isolate of BTV-4
(ISR2001/01). However, Seg-3 from this group of viruses is
clearly distinct from that of the BTV-2 (TUN2000/01, ITL2002/
07) and BTV-4 (SPA2003/01, MOR2004/02) isolates from the
western Mediterranean region, even though these strains also
belong to the western topotype.
In contrast, Seg-3 from the rest of the BTV-1, -9 and -16 isolates
from Greece, Cyprus, Bulgaria, Turkey and Israel, all belong to
the eastern topotype, but cluster into two separate lineages (sub-
groups) both supported by high bootstrap values (100% and 60%).
One lineage includes the BTV-16 isolates from Pakistan
(RSArrrr/16) and Israel (ISR2001/18) as well as BTV-16 isolates
(TUR2000/01, CYP2004/01, GRE1999/13) and BTV-9 isolates
(GRE1999/12, GRE1998/01, BUL1999/01) from Turkey, Cy-
prus, Bulgaria, and Greece, showing overall nucleotide similarity
of 97.7%–99.9% (Pi=0.0054, SD=0.0009). However, the three
Greek BTV-1 isolates (GRE2001/05, GRE2001/06, GRE2001/
07), along with the isolates from India (BTV-23/IND1998/01,
BTV-1/IND2001/01), Indonesia (BTV-3/INDO/1990) and As-
tralasia (BTV-1/AUSAsia) form a distinct lineage (75% bootstrap
support) that also shows overall nucleotide similarity 92.3%–
94.4% (Pi=0.0012, SD=0.0004), with the Indian and Greek
Figure 2. Schematic representation of VP3, showing the location of parsimony-informative sites found among viral isolates. The
three domains of VP3 (apical, carapace, and dimerization) according to Grimes et al., (1998) are indicated. Positions 213, 244, 461, 595, 786, and 811
that are conserved within each lineage are indicated in bold and correspond to Ile, Gln, Asp, Ile, Phe, Ser for the ‘west’ lineage and Val, His, Glu, Val,
Tyr, Ala for the ‘east’.
doi:10.1371/journal.pone.0006437.g002
VP3 Genes of BTV Isolates
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GTR + I + C model. The viruses included are listed intables 1 and 2. Isolate abbreviations: Serotype/origin (GRE: Greece, ISR: Israel, ZIM: Zimbabwe,
NIG: Nigeria, SUD: Sudan, MOR: Morocco, SPA: Spain, TUN: Tunisia, ITL: Italy, CORS: Corsica, USA: USA, CYP: Cyprus, BUL: Bulgaria, TUR: Turkey, IND:
India, AUSAsia: Australasia, INDO: Indonesia, TAIW: Taiwan, MAY: Malaysia, AUS: Australia, ISA: Indonesia, RSA: Reference strain)/year of isolation or
IAH dsRNA virus reference collection number. The tree is midpoint rooted for purposes of clarity. The numbers indicated on branches are non-
parametric bootstrap (NPB) probabilities and only values with P.0.6 are shown.
doi:10.1371/journal.pone.0006437.g003
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94%–94.4%).
A third distinct lineage was detected within the eastern Seg-3
topotype, containing isolates from south-east Asia and Australia
(BTV-16/ISA1991/01, BTV-2/TAIW/2003, BTV-6/INDO/
1990, BTV-1/MAY1987/01, BTV-21/INDO/1990, BTV-1/
INDO/1990, BTV-9/AUS1985/01, BTV-16/AUS1986/02 and
BTV-1/AUS/1979) supported by high bootstrap values (97%).
Phylogenetic analysis of the 59 region of the Seg-3 which
encodes part of the carapace domain (7-297 aa) gave almost
identical topologies and bootstrap support with those inferred
using the whole Seg-3 coding region. However, significant
divergence in topology and bootstrap support was revealed in
the trees inferred using the middle or the 39 coding region of Seg-3
(Figure S1, S2 and S3 - Supporting information).
Positive selection
Positive selection analysis was performed separately for the
western and eastern lineages of BTV. The SLAC and FEL
methods did not identify any sites in the western lineage which
gave evidence of positive selection significant at the p,0.1 level. In
the eastern lineage, codon site 78 (GlnRArg) (p=0.09) was
identified by the FEL method as being influenced by positive
selection.
The global estimate of dN/dS was 0.015 (95% likelihood profile
based confidence intervals, CI=0.01–0.02) for the western lineage
and 0.013 (95% CI=0.01–0.018) for the eastern lineage,
indicating strong purifying selection. A high number of negatively
selected codons were identified in both lineages. SLAC identified
147 negatively selected sites in the western lineage and 203 in the
eastern, while FEL identified 338 and 429 sites significant at the
p,0.1 level, respectively.
Near terminal non-coding regions (NCRs)
Comparisons of the near terminal NCRs of Seg-3 from the
BTV isolates (Table 1), along with other published sequences
(Table 2), showed no differences in their length. The NCRs
showed a higher level of conservation overall than the coding
region, suggesting an important functional role. The 17 bp
upstream-NCR was identical in all of the isolates compared, while
the 49 bp downstream-NCR showed only low levels of diversity
within each lineage (eastern Pi=0.049, SD=0.009; western
Pi=0.044, SD=0.008). The mean distance between lineages
was Dxy=0.121. In each case the conserved terminal hexanucleo-
tides were in complete agreement with the sequences reported for
BTV (+ve 59-GUUAAA------ACUUAC-39) [1,62]. Comparative
sequence analysis of the terminal NCRs, also confirmed the
existence of short inverted repeat sequences [3], indicating base
pairing between the 59 and 39 ends of the RNA transcripts
(Figure 4).
Discussion
In order to make meaningful comparisons of sequence data
derived from tissue culture adapted isolates of BTV, it is important
to know the effect that virus isolation and multiple passage in
embryonated chicken eggs and mammalian cell cultures may have
on the RNA sequence of individual genome segments. Although
only limited sequence data are available for the live vaccine strains
of BTV, in some cases it has been possible to compare their
sequences to those of the reference strains from which they were
derived. Indeed, initial comparisons of the South African reference
and vaccine strains of BTV-6 and BTV-9, suggest that multiple
passages in embryonated chicken eggs (60 or 70 passages
respectively) and in BHK cells (7 or 11 passages respectively) as
well as multiple plaque selections [63], have led to few if any
changes in RNA sequence (,0.4% variation in Seg-2, ,0.18%
variation in Seg-3 ) [64,65].
In the study presented here, full length nucleotide sequences
were generated for Seg-3 of twenty isolates of BTV, from the
eastern Mediterranean region (from Cyprus, Bulgaria, Turkey
Israel and Greece 1979, 1998–2001), as well as ten other reference
strains and isolates, from other parts of the world (Figure 1). These
data were compared to sequences for Seg-3 from 24 further BTV
strains that have already been published [14,42,66–70], providing
an analysis of the largest set of full-length BTV Seg-3 sequences to
date.
Comparison of the terminal NCRs of Seg-3 showed a high level
of sequence conservation (the 59 NCR was 100% conserved,
although some variability was evident in the 39 NCR (7.7% mean
overall variability), as reported in earlier studies [13,14,42]. These
comparisons also showed short inverted repeat sequences that are
consistent with base pairing between the 59 and 39 ends of the
mRNA transcripts (Figure 4) [3]. The formation of these partial
duplex structures between the terminal NCRs may influence the
secondary structure of the mRNA and consequently induce
formation of specific stem-loop structures, which it has been
suggested can interact with NS2 and may be involved in the
selection and packaging of the mRNA segments during virus
assembly [71,72,73]. Conserved terminal hexanucleotides and
adjacent inverted repeats are present in the NCRs of all 10 BTV
genome segments, suggesting that they provide an important role
as recognition signals for initiation of transcription and/or RNA
replication and packaging [62]. It is also possible that they play a
role in the efficient translation of viral mRNAs.
Although Seg-2 is the most variable region of the BTV genome,
a high level of conservation was observed between isolates of the
same serotype circulating in small geographic areas, suggesting a
lack of diversifying selection (diversifying selection drives rapid
differentiation of gene sequences and is one of the main forces
behind adaptive evolution) (for example BTV-11 in Northern
Colorado and BTV-4 in Greece and Turkey) [31,74].
As an indicator of the action of natural selection in gene
sequences the ratio of nonsynonymous (amino acid-altering) to
synonymous substitutions (silent) (dN/dS) is versatile and widely
used and provides an estimate of the selective pressure at the
protein level [75]. A value of dN/dS.1 means that non-
synonymous mutations offer fitness advantages to the protein
and have higher fixation probabilities than synonymous mutations
(diversifying or positive selection). On the other hand, dN/dS values
close to 0 mean that the protein is essentially conserved at the
amino acid level (purifying or negative selection imposed by
functional constraints) and dN/dS=1 corresponds to neutral
evolution. Global dN/dS values provide a means of assessing
adaptive evolutionary pressures acting on a gene [75]. Approx-
imately 36 to 43% of VP3 sites in both eastern and western BTV
lineages appeared to be evolving under purifying selection, with
dN/dS values of 0.013 and 0.015 respectively indicating ‘strong’
purifying selection. As expected, given its critical role in core
formation and function [1,6] VP3 is subjected to powerful
constraints and therefore appears unable to tolerate high levels
of sequence variation. The genetic distance between the eastern
and western lineages of Seg-3 (long internal tree branches,
Figure 3) was high compared to the intra-lineage distances (short
external tree branches, Figure 3). This could be an indication that
in VP3, multiple amino acid substitutions are accommodated in a
coordinated manner that preserves protein function and structure.
Moreover, the fact that aa positions 213, 244, 461, 595, 786, and
VP3 Genes of BTV Isolates
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possible co-variation of these amino acid positions, although this
requires further experimental examination.
Rapid divergence of the NS3 and VP2 genes of BTV during
experimental transmission between sheep, cattle and C. sonorensis,
have indicated that the virus is capable of rapid sequence changes
under appropriate conditions [26]. This suggests that the relatively
low rates of BTV evolution observed in nature are not simply due
to the innate properties of the genome replication mechanism (eg.
a high fidelity viral polymerase or proof-reading). However,
different selection forces and evolutionary constraints appear likely
to restrict the evolution of the different BTV genome segments,
with reassortment, genetic drift and founder effects contributing to
the gradual overall diversification of individual BTV strains [26].
Low levels of evolutionary change are previously been recorded
in other RNA arboviruses [76]. The requirement for replication in
diverse host species (e.g. mammals and invertebrates) imposes
important functional constraints and strong purifying-selection,
minimising genetic drift and reducing the rates of nucleotide
substitution [26,77]. However rapid phenotypic changes in the
virus due to mutations and founder effects may occasionally be
induced as the virus passes through genetic bottleneck during each
sequential passage between ruminant hosts and insect vectors [26].
BTV evolves with these constraints, potentially explaining how it
can circulate for many years in a single geographic area without
significant change, resulting in little or no evidence of temporal
variation during phylogenetic comparisons.
BTV-VP3 exhibits fewer evolutionary changes than VP2, VP5,
VP7 or NS3 [13]. This is reflected by the relatively small genetic
distances that were detected between the Greek isolates of BTV-1,
and the isolates of BTV-9 or BTV-16 (irrespective of their year of
isolation: 1999–2004), or their different origins within the eastern
Mediterranean region (Cyprus, Greece, Bulgaria or Turkey). A low
nucleotide diversity, ,0.4% (Pi=0.0027, SD=0.0005) was also
observed in Seg-3 between the eight Greek and one Cypriot isolate of
BTV-4. Maximum likelihood (ML) phylogenetic analysis showed
smallgeneticdistancesandindicatedalackofatemporaldistribution,
despite the 25 year period covered by these BTV-4 isolates (Figure3).
Overall negative selection appears to be the major evolutionary
force affecting nucleotide diversity and evolution rates of Seg-3. A
Figure 4. Sequence alignment of the 59 terminal NCRs determined, indicating base pairing with the 39 ends of the RNA transcripts.
Only divergent sequences are shown.
doi:10.1371/journal.pone.0006437.g004
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sequences of the same Greek isolates [29,78], indicating that
conservation of these eastern Mediterranean BTV-4 isolates is not
limited to VP3.
Geographic separation has resulted in divergence in BTV Seg-3
sequences that is consistent with the evolution of distinct viral
populations [13,14]. Phylogenetic analysis of Seg-3 therefore provides
a potential mechanism to determine the geographic origins of the
BTV incursions into South Eastern Europe. ML phylogenetic
comparisons using the best fitted model of nucleotide substitution,
separated the Seg-3 sequences of the Greek, Cypriot, Bulgarian,
Turkish and Israeli isolates into three distinct clusters/lineages, one
containing isolates of BTV-4 from a western-origin/western-topotype,
and two other clusters/lineages containing isolates of BTV-1, -9 and
-16 from an eastern origin/within the eastern-topotype.
Similar eastern and western origins for the Greek isolates were
previously inferred by analysis of Seg-10 [29]. Based on Seg-3
analyses two different subclusters of closely related BTV-4 isolates
circulating in the Mediterranean region were revealed. One
includes closely related Greek isolates of BTV-4 along with a
BTV-4 isolate from Cyprus 2004 and the reference strain
RSArrrr/04 (which derives from the BTV-4, ASOT 1 strain
isolated in 1969 in Cyprus). These isolates were also closely related
to a BTV-4 isolate from an outbreak in Israel during 2001,
indicating the existence of a BTV-4 sub-lineage in eastern
Mediterranean region. The second subcluster included BTV-4
isolates from Morocco, Spain, Tunisia, Italy and Corsica that
appear to have a western Mediterranean origin.
The results obtained with Seg-3 confirm the existence of at least
two separate gene pools of BTV-4 in the Mediterranean basin.
Potgieter et al (2005)[22] analyzed Seg-2 sequences of Greek
BTV-4 isolates, along with those originating from western
Mediterranean countries and found two different groups of
isolates circulating in this region. This indicates two different
sources for BTV-4 incursions in European countries, one from the
southeast and the other from the southwest (North Africa)
(Figure 1). Similar conclusions resulted after a more detailed
sequence analysis based on five genome segments (Seg-2, -7, -8, -9
and -10) of BTV-4 isolates from different Mediterranean countries
[31]. These analyses all support the conclusion that two subclusters
of BTV-4 have been circulating in southern Europe, one causing
incursions into Greece (1979, 1999–2000) and the second causing
epizootics into Italy, Spain, Corsica and Morocco from 2003
onward. Phylogenetic analysis has indicated a common origin for
the Portuguese BTV-4 isolates (2004–2006) and those from
Sardinia and Corsica (2003), indicating that viruses belonging to
this second cluster had recently spread to Portugal [30].
The Greek BTV-1, -9 and -16 isolates segregate into two
branches within the eastern topotype, reflecting different geo-
graphic origins. The Greek BTV-1 isolates are more closely
related to other eastern BTV-1 strains, particularly those from
India. Circulation of BTV-1 had not previously been detected in
the Mediterranean region [19]. Despite a lack of serological
evidence for BTV-1 infection in Turkey during a survey in the
early 1980s [79], the Greek strain of BTV-1 may have originated
from eastern Turkey or the Middle East. However the BTV-8,
BTV-6, and BTV-11 outbreaks in northern Europe, which started
during 2006 and 2008, were not derived from outbreaks in
contiguous territories. These events indicate that exotic strains of
the virus can originate from distant sources, suggesting that the
eastern Mediterranean strain of BTV-1 could have been
introduced directly from India (Figure 1). This serotype persisted
only for a relatively short period (2001) in Greece and did not
spread to other European countries.
Interestingly, the BTV-9 and -16 isolates analysed form a
separate sub-lineage that included isolates from Greece (BTV-16
and -9), Cyprus (BTV-16), Bulgaria (BTV-9), and Turkey (BTV-
16) along with more distantly related isolates from Israel (BTV-16)
and the reference strain RSArrrr/16 originating from Pakistan
[63]. BTV-9 and -16 isolates from Australia and Indonesia
analysed group to a separate sublineage. European strains
containing Seg-3 belonging to this sub-lineage appear to have
arrived from the Middle East. Evidence for BTV-9 infection was
provided by a serological survey conducted in western and
southern Anatolian Turkey during 1979–1980 [79]. Outbreaks
caused by this BTV type have been reported for several years in
Anatolian Turkey, Syria, Jordan and Israel in the period 1978–
1981 [19]. The first incursion of BTV-9 in Europe was reported in
Greece (Rhodes) during 1998. This serotype was also detected
during a second outbreak on mainland Greece, Bulgaria and
Turkey during 1999 [19]. High levels of nucleotide identity in Seg-
2 between the 1999 Greek and 2001 Italian BTV-9 isolates
(.99%) indicate that this strain also spread to Italy [22].
The first European strain of BTV-16 was isolated in 1999, from
outbreaks on the Greek islands in the eastern Aegean Sea [25]. A
close phylogenetic relationship was detected between the Greek,
Cypriot and Turkish isolates of BTV-16, with almost identical
Seg-3 sequences (99.4% similarity) to those isolates from Israel and
Pakistan (bootstrap values 100%), again suggesting that the virus
arrived in Europe from the east, possibly via Turkey (Figure 1).
Analyses of Seg-2 from the European BTV-16 isolates have
indicated an eastern origin [22,80] as well as a common origin
with the South African BTV-16 vaccine strain (derived from the
reference strain from Pakistan). Analyses of French (Corsica),
Italian and Israeli field isolates of BTV-16 indicate a recent
common ancestry with the vaccine strain and have demonstrated
reassortment with the BTV-2 vaccine strains, involving genome
segment 5 (NS1 gene) [22,81].
Since 1995, a live attenuated BTV-16 vaccine strain has been
used as part of a live pentavalent vaccine (prepared in South
Africa) containing BTV-2, -4, -6, -10 and -16, which was given
annually on a voluntary basis to a small number of susceptible
sheep in Israel [82]. Since 2004, BTV-16 has been removed from
this vaccine, for safety reasons. The high sequence identity (99.4%)
of Seg-3 from isolates belonging to different serotypes (BTV-9 and
-16), was also reported for Seg-10 of the same Greek isolates [29]
and indicates that reassortment involving replacement of Seg-2, or
Seg-3 and Seg-10 has occurred.
There is considerable evolutionary pressure on the orbiviruses
to maintain a stable and enzymatically functional core-particle.
The role of the VP3 protein therefore appears to be mainly
structural, and it is less affected by the nature of the hosts’ species
than the outer capsid proteins. The evolution of VP3 appears to be
driven primarily by random genetic drift coupled with strong
negative selection, resulting in low evolution rates. As a
consequence Seg-3 provides a valuable analytical target to trace
the origins of BTV strains during epizootics. However, the highly
conserved nature of this protein makes it necessary to use of long
sequences for these phylogenetic comparisons and makes it more
difficult to identify the temporal distribution of isolates during a
single epizootic, within a restricted geographic region. The 59
region of Seg-3 encodes part of the carapace domain (7–297aa)
and can be used as an alternative to the full sequence for the
prediction of the geographic origin of the various strains of BTV
with good proximity. This region of Seg-3 can be determined
directly by RT-PCR amplification and sequencing, potentially
facilitating future epidemiological studies of BTV. Up to now all
BTV incursions into south-eastern Europe, by viruses belonging to
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eastern Mediterranean strain) were from a geographic area located
to the east/southeast of Greece. Epidemiological and phylogenetic
analysis data indicate that the Middle East potentially represents
an important ecologic niche for these viruses, and a continuous
source for BTV further incursions into Europe. The continuous
circulation of different serotypes, including live vaccine strains, in
this geographic region provides the conditions of genetic
reassortment, and the generation of novel strains, potentially with
altered biological properties. The detection of essentially the same
Seg-3 in isolates belonging to different serotypes (i.e with divergent
Seg-2 sequences), indicates that genome segment reassortment has
occurred during the evolution of these strains, as analysed by
Nomikou et al (manuscript in preparation).
Supporting Information
Figure S1 Phylogenetic tree inferred with maximum likelihood
analysis using the 59 region of BTV Seg-3 (nucleotides 36 to 908)
and the GTR + I + C model. The viruses included are indicated in
tables 1 and 2. Isolate abbreviations: Serotype/origin (GRE:
Greece, ISR: Israel, ZIM: Zimbabwe, NIG: Nigeria, SUD: Sudan,
MOR: Morocco, SPA: Spain, TUN: Tunisia, ITL: Italy, CORS:
Corsica, USA: USA, CYP: Cyprus, BUL: Bulgaria, TUR: Turkey,
IND: India, AUSAsia: Australasia, INDO: Indonesia, TAIW:
Taiwan, MAY: Malaysia, AUS: Australia, ISA: Indonesia, RSA:
Reference strain)/year of isolation or IAH dsRNA virus reference
collection number. The numbers indicated on branches are non-
parametric bootstrap (NPB) probabilities and only values with
P.0.6 are shown.
Found at: doi:10.1371/journal.pone.0006437.s001 (2.50 MB TIF)
Figure S2 Phylogenetic tree inferred with maximum likelihood
analysis using the middle region of BTV Seg-3 (nucleotides 909 to
1778) and the GTR + I + C model. The viruses included are
indicated in tables 1 and 2. Isolate abbreviations: Serotype/origin
(GRE: Greece, ISR: Israel, ZIM: Zimbabwe, NIG: Nigeria, SUD:
Sudan, MOR: Morocco, SPA: Spain, TUN: Tunisia, ITL: Italy,
CORS: Corsica, USA: USA, CYP: Cyprus, BUL: Bulgaria, TUR:
Turkey, IND: India, AUSAsia: Australasia, INDO: Indonesia,
TAIW: Taiwan, MAY: Malaysia, AUS: Australia, ISA: Indonesia,
RSA: Reference strain)/year of isolation or IAH dsRNA virus
reference collection number. The numbers indicated on branches
are non-parametric bootstrap (NPB) probabilities and only values
with P.0.6 are shown.
Found at: doi:10.1371/journal.pone.0006437.s002 (2.49 MB TIF)
Figure S3 Phylogenetic tree inferred with maximum likelihood
analysis using the 39 region of BTV Seg-3 (nucleotides 1779 to
2648) and the GTR + I + C model. The viruses included are
indicated in tables 1 and 2. Isolate abbreviations: Serotype/origin
(GRE: Greece, ISR: Israel, ZIM: Zimbabwe, NIG: Nigeria, SUD:
Sudan, MOR: Morocco, SPA: Spain, TUN: Tunisia, ITL: Italy,
CORS: Corsica, USA: USA, CYP: Cyprus, BUL: Bulgaria, TUR:
Turkey, IND: India, AUSAsia: Australasia, INDO: Indonesia,
TAIW: Taiwan, MAY: Malaysia, AUS: Australia, ISA: Indonesia,
RSA: Reference strain) /year of isolation or IAH dsRNA virus
reference collection number. The numbers indicated on branches
are non-parametric bootstrap (NPB) probabilities and only values
with P.0.6 are shown.
Found at: doi:10.1371/journal.pone.0006437.s003 (2.63 MB TIF)
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